Evidence map›Paper›PMID 39823477›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

CircDNA2-Educated YTHDF2 Phase Separation Promotes PM

Jie Xu, Zhi Ling, Lijia Yin, Duo Xu, Shenshen Wu, Rui Chen

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. CircDNA2-Educated YTHDF2 Phase Separation Promotes PMAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jie XuYunnan Provincial Key Laboratory of Public Health and Biosafety & School of Public Health, Kunming Medical University, Kunming, 650500, P. R. China.
Zhi LingSchool of Public Health, Capital Medical University, Beijing, 100069, P. R. China.
Lijia YinSchool of Public Health, Capital Medical University, Beijing, 100069, P. R. China.
Duo XuSchool of Public Health, Capital Medical University, Beijing, 100069, P. R. China.
Shenshen WuSchool of Public Health, Capital Medical University, Beijing, 100069, P. R. China.
Rui ChenSchool of Public Health, Capital Medical University, Beijing, 100069, P. R. China.ORCID https://orcid.org/0000-0002-7003-6602

Funding

Applied Basic Research Foundation of Yunnan Province 202301AU070219Beijing Municipal Commission of Education KM202110025206Beijing Outstanding Young Talents JWZQ20240101024Discipline Team of Kunming Medical University 2024XKTDTS17Discipline Team of Kunming Medical University 2024XKTDYS01Discipline Team of Kunming Medical University CXTD202201Feinstein Institutes for Medical Research CX23YZ01Innovative Research Team of Yunnan Province 202405AS350016Joint Special Project of Yunnan Provincial Department of Science and TechnologyKunming Medical University for Applied Basic Research 202301AY070001-188National Key R&D Program of China 2022YFC2504100National Natural Science Foundation of China 82003499National Natural Science Foundation of China 82304175National Natural Science Foundation of China 82373606National Science Fund for Distinguished Young Scholars 82025031State Key Program of the National Natural Science Foundation of China 82230109
6 · The paper itself

Abstract

Substantial epidemiological evidence suggests a significant correlation between particulate matter 2.5 (PM

Indexed as

Cell Cycle ProteinsCell Transformation, NeoplasticLung NeoplasmsNuclear ProteinsParticulate MatterRNA-Binding ProteinsRNA, CircularGADD45 ProteinsHumansPhase SeparationCell Cycle ProteinsGADD45A protein, humanGADD45 ProteinsNuclear ProteinsParticulate MatterRNA-Binding ProteinsRNA, CircularYTHDF2 protein, humancircrnaliquid–liquid phase separationmalignant transformationPM2.5YTHDF2

Identifiers

PMID39823477
PMCPMC11984909

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.